NCT01933048View on ClinicalTrials.gov

Self-Administered Nasal Influenza Feasibility Study

PHASE4CompletedINTERVENTIONAL
Enrollment

1,077

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Influenza
Interventions
DRUG

FluMist

FluMist Intranasal Vaccine

Trial Locations (2)

78234

San Antonio Military Health System, Fort Sam Houston

92134

Naval Medical Center San Diego, San Diego

All Listed Sponsors
lead

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

NCT01933048 - Self-Administered Nasal Influenza Feasibility Study | Biotech Hunter | Biotech Hunter